Rexahn Pharmaceuticals Inc (NYSE American:RNN)

Delayed Data
As of Mar 16
 +0.03 / +1.83%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Rexahn Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 19.50 and a low estimate of 6.00. The median estimate represents a +678.44% increase from the last price of 1.67.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Rexahn Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.04%
Growthannually -135.00%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.